DK506774A - - Google Patents

Info

Publication number
DK506774A
DK506774A DK506774A DK506774A DK506774A DK 506774 A DK506774 A DK 506774A DK 506774 A DK506774 A DK 506774A DK 506774 A DK506774 A DK 506774A DK 506774 A DK506774 A DK 506774A
Authority
DK
Denmark
Application number
DK506774A
Other languages
Danish (da)
Inventor
E J Cragoe Jr
O W Woltersdorf Jr
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK506774A publication Critical patent/DK506774A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/72Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings and other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK506774A 1973-10-12 1974-09-26 DK506774A (en:Method)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40596473A 1973-10-12 1973-10-12
US05/492,943 US4006180A (en) 1973-10-12 1974-07-31 [1,3-Dihydroxy-2-substituted and 2,2-disubstituted-indanyloxy(or thio)]alkanoic acids

Publications (1)

Publication Number Publication Date
DK506774A true DK506774A (en:Method) 1975-06-09

Family

ID=27019306

Family Applications (1)

Application Number Title Priority Date Filing Date
DK506774A DK506774A (en:Method) 1973-10-12 1974-09-26

Country Status (8)

Country Link
US (1) US4006180A (en:Method)
JP (1) JPS5077355A (en:Method)
DE (1) DE2448393A1 (en:Method)
DK (1) DK506774A (en:Method)
FR (1) FR2247217B1 (en:Method)
GB (1) GB1480239A (en:Method)
NL (1) NL7412830A (en:Method)
SE (1) SE7412047L (en:Method)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5001255A (en) * 1984-12-04 1991-03-19 Sandoz Pharm. Corp. Idene analogs of mevalonolactone and derivatives thereof
EP1465649A4 (en) * 2001-11-21 2007-07-11 Burnham Inst METHOD AND COMPOSITIONS FOR DEREPRIMATING IAP-INHIBITED CASPASE
US20050119176A1 (en) * 2001-11-21 2005-06-02 The Burnham Institute Methods and compositions for derepression of IAP-inhibited caspase
US20060258581A1 (en) * 2001-11-21 2006-11-16 Reed John C Methods and composition for derepressions of IAP-inhibited caspase
US6858614B2 (en) 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenolic guanidine sodium channel blockers
US6858615B2 (en) * 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenyl guanidine sodium channel blockers
AU2003233228A1 (en) * 2002-05-03 2003-11-17 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Novel spiro ketone and carboxylic acid derivatives as specific inhibitors for (po3h2) ser/(po3h2)thr-pro-specific peptidyl-prolyl-cis/trans-isomerases
US6903105B2 (en) * 2003-02-19 2005-06-07 Parion Sciences, Inc. Sodium channel blockers
US20050090505A1 (en) * 2003-08-18 2005-04-28 Johnson Michael R. Methods of reducing risk of infection from pathogens
US20090253714A1 (en) * 2003-08-20 2009-10-08 Johnson Michael R Methods of reducing risk of infection from pathogens
US7745442B2 (en) 2003-08-20 2010-06-29 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens
US20070003535A1 (en) * 2005-03-17 2007-01-04 Reed John C Methods and compositions for derepression of IAP-inhibited caspase
WO2006102068A2 (en) * 2005-03-17 2006-09-28 The Burnham Institute Methods and compositions for derepression of iap-inhibited caspase
US20110183358A1 (en) * 2005-03-17 2011-07-28 The Burnham Institute Methods and compositions for derepression of iap-inhibited caspase
US20070021439A1 (en) * 2005-07-25 2007-01-25 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens with soluble amide and ester pyrazinoylguanidine sodium channel blockers
US20090043099A1 (en) * 2006-03-17 2009-02-12 The Burnham Institute Methods and compositions for derepression of IAP-inhibited caspase
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
HUE032891T2 (hu) 2012-12-17 2017-11-28 Parion Sciences Inc Klórpirazin-karboxamid-származékok nem kielégítõ nyálkahártya-hidratáció által elõsegített megbetegedések kezelésére
CN104995178B (zh) 2012-12-17 2018-06-26 帕里昂科学公司 3,5-二氨基-6-氯-n-(n-(4-苯基丁基)甲脒基)吡嗪-2-甲酰胺化合物
US9102633B2 (en) 2013-12-13 2015-08-11 Parion Sciences, Inc. Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1498459A (en:Method) * 1965-07-30 1968-01-08
US3668241A (en) * 1968-11-25 1972-06-06 Merck & Co Inc Substituted 1-oxoinden-5-yloxy alkanoic acids
US3704314A (en) * 1968-11-25 1972-11-28 Merck & Co Inc (1-oxo-2-alkylideneindanyloxy) and (1-oxo - 2 - alkylideneindanylthio) alkanoic acids
US3776944A (en) * 1971-09-16 1973-12-04 Warner Lambert Co Tetraloneoxy acetic acids and esters thereof
US3906032A (en) * 1972-11-10 1975-09-16 Squibb & Sons Inc Dihydroxy-tetrahydronaphthyoxyisobutyric acids and alkyl esters and salts thereof

Also Published As

Publication number Publication date
NL7412830A (nl) 1975-04-15
FR2247217B1 (en:Method) 1978-02-03
DE2448393A1 (de) 1975-04-17
FR2247217A1 (en:Method) 1975-05-09
SE7412047L (en:Method) 1975-04-14
GB1480239A (en) 1977-07-20
JPS5077355A (en:Method) 1975-06-24
US4006180A (en) 1977-02-01

Similar Documents

Publication Publication Date Title
AR201758A1 (en:Method)
AU476761B2 (en:Method)
AU465372B2 (en:Method)
AR201235Q (en:Method)
AR201231Q (en:Method)
AU474593B2 (en:Method)
AU474511B2 (en:Method)
AU474838B2 (en:Method)
AU471343B2 (en:Method)
AU465453B2 (en:Method)
AU465434B2 (en:Method)
AU450229B2 (en:Method)
AU476714B2 (en:Method)
AR201229Q (en:Method)
AU466283B2 (en:Method)
AR199451A1 (en:Method)
AU476696B2 (en:Method)
AU472848B2 (en:Method)
AU477823B2 (en:Method)
AU461342B2 (en:Method)
AU471461B2 (en:Method)
AR200256A1 (en:Method)
AU476873B1 (en:Method)
AR210729A1 (en:Method)
AR193950A1 (en:Method)